| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/30/2013 | CN102895220A Ketoprofen intravenous administration preparation and preparation method thereof |
| 01/30/2013 | CN102895219A Application of astaxanthin in fetal alcohol spectrum disorders (FASD) |
| 01/30/2013 | CN102895207A Diclofenac sodium sustained-release tablet and preparation method thereof |
| 01/30/2013 | CN102895202A Cefetamet pivoxil hydrochloride dispersible tablet and preparation method thereof |
| 01/30/2013 | CN102895163A Natural green talcum powder |
| 01/30/2013 | CN102895147A Toothpaste with anti-inflammation and anti-allergic effects and making technology thereof |
| 01/30/2013 | CN102895144A Composition of skin external application containing ginseng fruit extracts |
| 01/30/2013 | CN102894241A Processing technology for efficiently increasing gastrodin content in gastrodia elata blume |
| 01/30/2013 | CN102894229A Natural feed additive with functions of relieving diarrhea, resisting bacteria and eliminating inflammation and preparation method thereof |
| 01/30/2013 | CN102423490B Nano-hybrid of brufen and hydrotalcite-like and preparation method thereof |
| 01/30/2013 | CN102370807B Health-care snake medicated wine |
| 01/30/2013 | CN102370805B Snake medicated wine for enhancing strength |
| 01/30/2013 | CN102335289B Snake medicinal liquor for removing rheumatism and reducing hypertension |
| 01/30/2013 | CN102250212B Matrix metalloproteinase-9 polypeptide inhibitor 5 and use thereof |
| 01/30/2013 | CN102228696B Polyethylene glycol-polyvinyl alcohol copolymer-metaxalone prodrug and synthesis method thereof |
| 01/30/2013 | CN102228441B Dexibuprofen sustained-release pellet and preparation method thereof |
| 01/30/2013 | CN102210685B Application of ectoine and derivatives thereof in preparing medicament for preventing and treating digestive tract diseases caused by chemotherapy medicaments |
| 01/30/2013 | CN102204950B Method for extracting flavonoid from liquorice waste residue |
| 01/30/2013 | CN102172397B In vivo targeting of dendritic cells |
| 01/30/2013 | CN102058581B Ophthalmic gel |
| 01/30/2013 | CN101879156B Medicinal composition and application thereof |
| 01/30/2013 | CN101780124B Capparis acutifolia sweet exact and preparation method and application thereof |
| 01/30/2013 | CN101564436B Method for separating and extracting lipo-alkaloids in Radix Aconiti Kusnezoffi class of traditional Mongolian medicine |
| 01/30/2013 | CN101553256B Phenylpropionamide compounds and the use thereof |
| 01/30/2013 | CN101528681B New sulfonamide derivatives as bradykinin antagonists |
| 01/30/2013 | CN101229295B Bone regeneration pain-relieving plaster |
| 01/29/2013 | US8362218 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8361962 Tricyclic inhibitors of JAK |
| 01/29/2013 | US8361751 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 01/29/2013 | US8361519 Combination herbal product to benefit respiratory tract in people exposed to smoke |
| 01/29/2013 | US8361499 Controlled release hydrocodone formulations |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/29/2013 | CA2448665C Sustained-release analgesic compounds |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2343929C Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/24/2013 | WO2013013003A1 Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation |
| 01/24/2013 | WO2013012918A1 Heterocyclic compounds and uses thereof |
| 01/24/2013 | WO2013012806A2 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 01/24/2013 | WO2013012715A1 Methods for treating inflammation |
| 01/24/2013 | WO2013012644A1 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs |
| 01/24/2013 | WO2013012485A2 Novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/24/2013 | WO2013012138A1 Lesion-marking receptor, and drug transporter for the treatment of a lesion-related ailment |
| 01/24/2013 | WO2013012118A1 Novel phenylester compound and pharmaceutical compositions for preventing or treating inflammatory diseases comprising the same |
| 01/24/2013 | WO2013012117A1 Pharmaceutical compositions for preventing or treating inflammatory diseases, comprising phytosterol compound |
| 01/24/2013 | WO2013011489A1 Adenine derivatives having immunomodulating anti-inflammatory and analgesic activity |
| 01/24/2013 | WO2013011033A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | WO2013010881A1 NEW CRTh2 ANTAGONISTS |
| 01/24/2013 | WO2013010869A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors |
| 01/24/2013 | WO2013010868A1 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors |
| 01/24/2013 | WO2013010839A1 Novel and selective ccr2 antagonists |
| 01/24/2013 | WO2013010400A1 Compounds based on ibuprofen, preparation methods, uses and pharmaceutical preparation thereof |
| 01/24/2013 | WO2012148247A3 Pharmaceutical composition containing oleanolic acid acetate as an active ingredient for preventing or treating tlr- or il-6-mediated diseases |
| 01/24/2013 | US20130023879 Method for augmenting, reducing, and repairing bone with thermoplastic materials (as amended) |
| 01/24/2013 | US20130023588 Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| 01/24/2013 | US20130023584 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023583 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023576 Pyrazole Compounds as CRTH2 Antagonists |
| 01/24/2013 | US20130023564 Piperidinyl derivative as a modulator of chemokine receptor activity |
| 01/24/2013 | US20130023556 Autotaxin inhibitors |
| 01/24/2013 | US20130023554 5-phenylpyrazolopyridine derivatives, preparation and therapeutic use thereof |
| 01/24/2013 | US20130023538 Heteroaryl Derivatives as CFTR Modulators |
| 01/24/2013 | US20130023530 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 01/24/2013 | US20130023529 Methods Involving Aldose Reductase Inhibitors |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 01/24/2013 | US20130023520 Anaesthetic eye solution and method of use |
| 01/24/2013 | US20130023514 Substituted pyrrolotriazines as protein kinase inhibitors |
| 01/24/2013 | US20130023512 Compositions for Combating Beta-Lactamase-Medicated Antibiotic Resistance Using Beta-Lactamase Inhibitors Useful For Injection |
| 01/24/2013 | US20130023510 Arachidonic acid analogs and methods for analgesic treatment using same |
| 01/24/2013 | US20130023504 Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023499 Certain substituted amides, method of making, and method of use thereof |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023492 Pharmaceutical compositions comprising plant-based polysaccharides and uses thereof |
| 01/24/2013 | US20130023489 Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130022695 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 01/24/2013 | US20130022694 Method for treating or relieving inflammatory bowel disease |
| 01/24/2013 | US20130022681 Granules for pharmaceutical preparations, methods and apparatus for their production |
| 01/24/2013 | US20130022679 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 01/24/2013 | US20130022663 Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula |
| 01/24/2013 | US20130022630 Method for treating amyloid disease |
| 01/24/2013 | US20130022616 Interleukin-31 Monoclonal Antibody |
| 01/24/2013 | US20130022607 Mucosal vascular addressins and uses thereof |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/24/2013 | US20130022586 Production and use of bacterial histamine |
| 01/24/2013 | US20130022580 Preparation and use of meristematic cells belonging to the dendrobium phalaenopsis, anisellia, polyrrhiza, vanilla, cattleya and vanda genera with high content of phenylpropanoids, hydrosoluble polysaccharides and extensins |
| 01/24/2013 | US20130022559 Methods For Inhibiting Tyrosinase Using an Extract of Laminaria Saccharina |
| 01/24/2013 | US20130022558 Methods For Imrproving the Appearance of Hyperpigmented Spot(s) and Skin Tone |
| 01/24/2013 | US20130022540 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | CA2842316A1 Novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/24/2013 | CA2842190A1 Heterocyclic compounds and uses thereof |
| 01/24/2013 | CA2842067A1 Novel il-17r-ecd mutants |
| 01/24/2013 | CA2842034A1 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 01/24/2013 | CA2841964A1 Methods of treating pain |